Anthropic added Novartis CEO Vas Narasimhan to its board, making him the first pharmaceutical executive on the AI startup’s governing body. The appointment highlights growing crossover between AI and healthcare, with an emphasis on governance and industry expertise rather than immediate financial impact.
Anthropic added Novartis CEO Vas Narasimhan to its board, making him the first pharmaceutical executive on the AI startup’s governing body. The appointment highlights growing crossover between AI and healthcare, with an emphasis on governance and industry expertise rather than immediate financial impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
